| IPFPX | VIVIX | IPFPX / VIVIX | |
| Total Expense Ratio | 0.96 | 0.04 | 2,400% |
| Annual Report Gross Expense Ratio | 1.07 | 0.04 | 2,675% |
| Fund Existence | 16 years | 28 years | - |
| Gain YTD | 4.039 | 3.476 | 116% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 5000000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 337M | 218B | 0% |
| Annual Yield % from dividends | 1.64 | 2.04 | 80% |
| Returns for 1 year | 17.79 | 15.99 | 111% |
| Returns for 3 years | 15.42 | 37.10 | 42% |
| Returns for 5 years | 32.16 | 62.11 | 52% |
| Returns for 10 years | 79.04 | 163.58 | 48% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MDSKX | 28.55 | 0.20 | +0.71% |
| iShares Russell 2000 Small-Cap Idx Inv A | |||
| LRSYX | 21.18 | 0.12 | +0.57% |
| Lord Abbett Small Cap Value I | |||
| SMVZX | 12.77 | 0.01 | +0.08% |
| Virtus Ceredex Mid-Cap Value Equity R6 | |||
| LVFLX | 16.04 | 0.01 | +0.06% |
| Lord Abbett Focused Large Cap Value R6 | |||
| JUEPX | 26.69 | -0.23 | -0.85% |
| JPMorgan US Equity R3 | |||